Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock ...

KEEN to lose weight in 2025? So are almost half of our readers. While weight-loss jabs, similar to Ozempic, boomed in popularity last year, Sun Health research shows you are not interested. Our ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

As we enter a new year armed with resolutions to improve our lives, there’s a good chance we’ll also be carrying something ...

"I wish I could say this was the worst I’ve ever been treated by a medical professional... but it’s not. It’s just the most ...

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

Genetics contribute between 40% and 70% of what determines a person’s weight, and the rest is environmental factors like diet, exercise, medications, stress, sleep patterns and overall ...

This Summerville couple topped 360 pounds each but have since lost more than 350 pounds combined. It took lifestyle changes, ...

"My mental health has drastically improved, I attribute that mostly to the fitness and getting outside more often," Tonilyn Garegnani told Newsweek.

Hershey (NYSE: HSY) isn't normally viewed as a high-yield stock, but its dividend yield of 3.2% today is near its highest ...

This top healthcare company trades at 13 times forward earnings. It has a diverse portfolio of products, yields 3.6% at the ...